-
IntroducedFeb 19, 2025
-
Passed Senate
-
Passed House
-
Signed into Law
Chimeric Antigen Receptor T-cell Therapy; Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc.
Summary/Bill Text
Comments on SB 876
Tweets
Whip Lists
Sponsors
Votes
Actions
- Feb 19, 2025 | Senate
- Filed
Bill Texts
Documents